6 companies in Third Rock Ventures's investment portfolio.
Back to Third Rock Ventures profile“Creates and builds breakthrough biopharmaceutical companies by combining cutting-edge science with experienced drug development teams.”
Biotechnology company developing gene therapies for severe genetic diseases and cancer using advanced gene editing technologies.
Precision medicine company developing targeted therapies for cancer and rare diseases using genomics-based drug discovery.
Editas Medicine, Inc., (formerly Gengine, Inc.), is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology.
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
A clinical-stage biopharmaceutical company focused on developing novel therapies for psychiatric and neurological conditions.